ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease: Developed by the Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 

Thursday, October 9, 2025

Submitted by

EACTS Staff

Source

Source Name: European Journal of Cardio-Thoracic Surgery

Source URL: https://academic.oup.com/ejcts/article/67/8/ezaf276/8242828

Author(s)

Fabien Praz, Michael A Borger, Jonas Lanz, Mateo Marin-Cuartas, Ana Abreu, Marianna Adamo, Nina Ajmone Marsan, Fabio Barili, Nikolaos Bonaros, Bernard Cosyns, Ruggero De Paulis, Habib Gamra, Marjan Jahangiri, Anders Jeppsson, Robert J M Klautz, Benoit Mores, Esther Pérez-David, Janine Pöss, Bernard D Prendergast, Bianca Rocca, Xavier Rossello, Mikio Suzuki, Holger Thiele, Christophe Michel Tribouilloy, Wojtek Wojakowski, ESC/EACTS Scientific Document Group

The 2025 ESC/EACTS Guidelines for the management of valvular heart disease (VHD) are an update to the 2021 version of this document. Key topics that have been updated include the central role of the Heart Team, emphasizing patient-centered decision-making; the importance of Heart Valve Centers for managing complex patients; advanced diagnostic imaging with clearly defined diagnostic criteria for specific VHD pathologies, including aortic stenosis and multiple valvular disease; and appropriate indications and timing for different interventional options for patients with VHD.